FDA Joins Forces With Customs Office To Beef Up Scrutiny of Drug Packages At Borders
Executive Summary
The US FDA and the US customs office have agreed to team up and establish an expanded scientific presence at International Mail Facility locations deemed “high risk” ports of entry to deter illegal opioids and counterfeit drugs from entering US borders.
You may also be interested in...
US/India Operation Intercepts Unapproved Drugs, Drug/Device Products
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.
Opioids, Old Initiatives Dominate FY 2020 US FDA Funding Increase
The agency requested a funding increase in part to implement 2018 legislation intended to combat the opioid crisis, but also to support many initiatives in last year's budget request.
Gottlieb's Priority For Proposed Opioid Money Is Mail Facilities
US FDA commissioner says primary use of proposed budget boost would be border security; budget documents state that special opioid epidemic funding also would support regulatory science and diagnostic development.